In A172 glioblastoma cells, TRAIL turned out to be the critical mediator of IFNα/BV6-induced cell death, since genetic silencing of TRAIL or DR5 protects cells from cell death upon IFNα/BV6 cotreatment. Here, IFNA2 is linked to glioblastoma.